Inna Markovna Chen
Herlev Sygehus
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Inna Markovna Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07802418 · Molecularly Tailored Therapy in Advanced Pancreatic CancerHerlev Hospital · not yet recruiting · Pancreatic Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:53 UTC. The ranking covers the 200 most relevant of 21 PubMed records, and a shared surname and initials can bring in a namesake. All 21 on PubMed
- 708 citationsRCR 16.5
- 499 citationsRCR 11.9
- 450 citationsRCR 9.8
- Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.Blood · 2017251 citationsRCR 8.2
- 161 citationsRCR 3.5
- 159 citationsRCR 3.3
- 108 citationsRCR 3.9
- Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC).J Clin Oncol · 202294 citationsRCR 5.8
- COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.J Immunother Cancer · 202278 citationsRCR 5.2
- Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).Pediatr Blood Cancer · 201555 citationsRCR 1.5